ft 28 jan 94 technolog sandoz split r amp differ like mani big pharmaceut group sandoz switzerland live nightmar discov drug new categori see anoth compani bring competitor compound market first one reason split develop depart away research activ britain glaxo announc similar move last year decid develop product go full room half measur say ur barloch chief execut sandoz reason chang come research side rapid advanc biochemistri chang natur research manag past pharmaceut research chemic base proceed rel gentl pace rise biochemistri becom fast move pharmaceut compani recognis speed advanc biotechnolog make imposs keep hous laboratori speed front consequ tend set co oper arrang independ biotechnolog laboratori start compani sandoz 30 arrang consum tenth sfr1 2bn pound 540m r amp budget barloch convinc number rise yet good feel right balanc trend increas say point alway difficult find research manag skill requir much greater need someon know happen basic research find lead new compound abl decid quickli co oper deal enter one keep matter judgment past slow assum person found argu much ask look develop well event believ manag develop involv test discoveri point put market demand differ skill research manag develop question set prioriti part systemat creativ run way similar product centr measur result set clear target sandoz notori slow develop depart past year ago brought manag consult mckinsey tri speed process last year set project team approach still feel among best barloch admit confid catch claim split lead greater bureaucraci tri segment respons flow product want give full respons head differ section reduc matrix minimum develop far expens part r amp process especi clinic studi thu group believ must concentr research effort find call number one compound clearli ahead competit longer worth follow guy even fast develop depart becom difficult catch barloch say cannot count guy make mistak